News

/News

Strategic Partnership with Mylan NV Announced Today

Today, Atomo Diagnostics was announced as a strategic partner to Mylan N.V. as part of the global pharmaceutical company's plans to commercialize CE-Marked in vitro HIV rapid diagnostic tests for self-testing in low- and [...]

September 24th, 2018|

Strategic Partnership Announcement: Atomo Diagnostics and Owen Mumford

Today, Atomo Diagnostics and Owen Mumford Ltd announced a strategic partnership for commercialisation of innovative HIV rapid tests in European markets Owen Mumford is a major healthcare company and device [...]

June 5th, 2018|

Strategic Partnership Announcement: Atomo Diagnostics and Access Bio

Today, Atomo Diagnostics and Access Bio Inc. jointly announced a strategic partnership to leverage the respective strengths of both companies and expand point of care HIV testing in global markets. [...]

January 23rd, 2018|

Atomo HIV Self Test approved by Expert Review Panel

Atomo Diagnostics' CEO, John Kelly, today announced that the Atomo HIV Self Test has been approved by the World Health Organisation’s Expert Review Panel for Diagnostics (ERP-D); a special process determined [...]

December 6th, 2017|

CE Marking granted for Atomo HIV Self Test

Atomo Diagnostics' CEO John Kelly announced today that the Atomo HIV Self Test has been granted CE Marking by a European Union Notified Body. The company is now actively engaging with commercialisation and distribution [...]

October 10th, 2017|

CEO John Kelly welcomes Doris-Ann Williams MBE to the Board of Atomo

Atomo Diagnostics has today announced that Doris-Ann Williams MBE, has been appointed to join its Board of Directors. Doris-Ann is Chief Executive of the British In Vitro Diagnostics Association (BIVDA) [...]

April 25th, 2017|

Canadian Government Fund Invests in Atomo

Delighted to welcome new investors for 2017, earlier this month Atomo Diagnostics announced backing from Grand Challenges Canada (GCC). Investment from the Canadian Government-funded agency totalling US$1 million (A$1.31 million, [...]

February 20th, 2017|

AtomoRapid featured in latest issue of Australian Biochemist

The December issue of Australian Biochemist is out and Atomo Diagnostics is highlighted in its Special Technical Feature on microfluidics and molecular diagnostic technologies that have revolutionised testing for infectious [...]

December 23rd, 2016|

Award-winning AtomoRapid diagnostic platform on show at Medica 2016

Next week, from 14 to 17 November, the team from Atomo Diagnostics will be at the world's largest annual medical trade fair - Medica.  The 4-day event, held in Dusseldorf, Germany, is [...]

November 11th, 2016|

OEM Partner NG Biotech Unveils Next Generation Integrated hCG Blood Pregnancy Test

Atomo Diagnostics is delighted to announce that we have been working with French biotechnology company, NG Biotech, to develop the world’s first fully-integrated blood-based rapid test for detection of hCG [...]

November 8th, 2016|